Evidence map›Paper›PMID 40527980›Full record

ArticleBone marrow transplantation2025

Clinical outcomes of offspring and matched unrelated donor transplants in relapsed or refractory severe aplastic anemia patients aged 40-50: a retrospective analysis from the CBMTR over the past decade.

Xin Zhao, Yu-Ping Zhang, Bao-Dong Ye, Pei-Hua Lu, Jie-Ping Chen, Jian-Ping Zhang, Xin Li, Guo-Hong Su, Yan-Ming Zhang, Er-Lie Jiang and 11 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Xin Zhao *Peking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Yu-Ping Zhang *Department of Hematology, Guangzhou First People's Hospital, Institute of Blood Transfusion and Hematology Guangzhou Medical University, Guangzhou, China.
Bao-Dong YeDepartment of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Pei-Hua LuDepartment of Hematology, Beijing Lu Daopei Hospital, Beijing, China.ORCID http://orcid.org/0000-0002-6331-7369
Jie-Ping ChenDepartment of Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China.
Jian-Ping ZhangDepartment of Hematology, Hebei Yanda Lu Daope Hospital, Langfang, Hebei, China.
Xin LiDepartment of Hematology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Guo-Hong SuDepartment of Hematology, Cangzhou Central Hospital, Cangzhou, Hebei, China.
Yan-Ming ZhangDepartment of Hematology, Huai'an Second People's Hospital, Huai'an, Jiangsu, China.
Er-Lie JiangState Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Disease Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical Science & Peking Union Medical College, Tianjin, China.
Fang ZhouDepartment of Hematology, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, China.
Dai-Hong LiuDepartment of Hematology, General Hospital of PLA (People's Liberation Army of China), Beijing, China.ORCID http://orcid.org/0000-0003-3334-9113
Zi-Min SunDepartment of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China.
Wei-Wei QinDepartment of Hematology, Tangdu Hospital Fourth Military Medical University, Xi'an, China.
Hai YiDepartment of Hematology, The General Hospital of Western Theater Command, PLA, Chengdu, China.ORCID http://orcid.org/0000-0003-3794-266X
Xue-Hong RanDepartment of Hematology, Weifang People's Hospital, Weifang, Shandong, China.
Ya-Jing XuDepartment of Hematology, Xiangya Hospital of Central South University, Changsha, Hunan, China.
Xi ZhangDepartment of Hematology, Xinqiao Hospital of Army Medical University (Third Military Medical University), Chongqing, China.ORCID http://orcid.org/0000-0002-8548-2832
Xiao-Jun HuangPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.ORCID http://orcid.org/0000-0002-2145-6643
Shun-Qing WangDepartment of Hematology, Guangzhou First People's Hospital, Institute of Blood Transfusion and Hematology Guangzhou Medical University, Guangzhou, China. eywangshq@scut.edu.cn.ORCID http://orcid.org/0000-0001-9418-4901
Lan-Ping XuPeking University Institute of Hematology, Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. lpxu_0415@sina.com.ORCID http://orcid.org/0000-0002-0267-1081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40527980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.